DZ Bank’s AtriCure ATRC Stock Holding History

DZ Bank’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-280,620	Closed	-$5.76M	–	869
2018 Q1	$5.76M	Buy	+280,620	New	+$5.07M	0.02%	375

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HEC

Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

DZ Bank's ATRC Position: Q2 2018 in Review

DZ Bank sold out of AtriCure (ATRC) in Q2 2018, closing a stake of 280,620 shares — an estimated $5.76M sold.

DZ Bank first reported a position in ATRC in Q1 2018 and held it in 1 quarter. The position peaked at $5.76M in Q1 2018. 108 funds tracked by Wall St. Rank hold ATRC as of Q2 2018.

DZ Bank reported no remaining AtriCure position as of Q2 2018 after selling out during the quarter.
DZ Bank sold 280,620 AtriCure shares in Q2 2018, an estimated $5.76M.
DZ Bank first reported a position in AtriCure in Q1 2018 and held it in 1 quarter.
DZ Bank's AtriCure position peaked at $5.76M in Q1 2018.
108 funds tracked by Wall St. Rank held AtriCure as of Q2 2018.

Based on DZ Bank's 13F filing for Q2 2018, filed 14 Aug 2018.